Navigation Links
Ben-Gurion U. researchers develop techniques to manipulate plant adaption in arid climates
Date:2/15/2011

BEER-SHEVA, ISRAEL, February 15, 2011 Ben-Gurion University of the Negev researchers have developed techniques to manipulate root development functionality that can help plants better adapt to hostile growing environments.

In a recent paper published in the prestigious journal The Plant Cell, BGU researchers were able show that by manipulating a specific gene they could impact lateral root growth. Lateral root (LR) development is a highly regulated process that determines a plant's growth and ability to adapt to life in different environmental conditions.

The researchers identified ABI4, a master-gene that controls LR development, then mutated the gene and constructed transgenic plants in which this gene is over-expressed. They demonstrated that the ABI4 gene functions at a central junction that determines the accumulation of signals from three different plant hormones. The balance and manipulation of these signals, achieved via ABI4, regulates root structure development.

According to the research conducted by BGU student Doron Shkolnik-Inbar and Prof. Dudy Bar-Zvi in BGU's Department of Life Sciences, "the revolutionary research will allow control and manipulation of the level of root branching, enabling plants to adapt to arid soils or high salinity."


'/>"/>

Contact: Andrew Lavin
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1

Related biology news :

1. Ben-Gurion University of the Negev researchers help find that hypnosis can induce synesthesia
2. Ben-Gurion University of the Negev to host
3. Ben-Gurion University of the Negev researchers develop new reversible, green window technology
4. Ben-Gurion University engineers develop technique to help combat nuclear proliferation
5. Ben-Gurion University of the Negev signs collaborative contract with Bayer CropScience
6. Ben-Gurion University research and technology used in new solar energy farm
7. Ben-Gurion U. researchers reveal connection between cancer and human evolution
8. 1 in 6 health workers wont report in flu pandemic -- study by Ben-Gurion U. researchers
9. Ben-Gurion U. developing new computer techniques to analyze historic Hebrew and Arabic documents
10. Ben-Gurion University of the Negev technology being developed for use in Jordan desalination plant
11. Ben-Gurion University Alzheimers researcher demonstrates specific immune response to vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Wis. , Jan. 15, 2015  BellBrook Labs, ... drug discovery, announced the launch of a TR-FRET ... the company,s Transcreener UDP Assay, a high throughput ... The new assay will allow for sensitive detection ...
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
(Date:1/22/2015)... , Jan. 22, 2015 Infinisource has launched its new ... G2 model. The G2 sets a higher standard for collecting ... capital management solution. With plug-and-play installation, touch screen interface and ... provides a robust time collection solution for the small to ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2Infinisource's NXG series sets new time clock standard 2
... HILL, N.C. Scientists at the University of North Carolina ... long-lasting pain relief through an ancient medical practice. ... edition of Molecular Pain , UNC researchers describe how ... relief in animal models. They call this new therapeutic approach ...
... (ST. LOUIS): The Royal Botanic Gardens, Kew (RBG Kew), ... Botanical Garden (NYBG) and the Missouri Botanical Garden (MBG), ... modern, online catalog of the world,s plantsto be made ... include the compilation of information on up to 400,000 ...
... Antarctica is perennially covered in ice. It is exposed ... extreme shade, and, during the winter, 24-hour darkness. But, ... is home. To study them, Dr. Rachel Morgan-Kiss from ... to Antarctica to sample the ice-covered lake. The article ...
Cached Biology News:Pain relief with PAP injections may last 100 times longer than a traditional acupuncture treatment 2Botanical institutions announce plans to create first online World Flora 2Botanical institutions announce plans to create first online World Flora 3Research on carbon-consuming life-forms in Antarctica published in JoVE 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/27/2015)... 2015   PureTech , a science and technology ... products and technologies in the healthcare sector, announced today ... and Member of the Board of Directors of Sanofi, ... has been a pleasure to know Chris for many ... be working together more closely now," said Dr. ...
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript,s ... judgment notwithstanding the verdict, a new trial, and remittitur. ...
(Date:2/26/2015)... , Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics ... a life sciences company that develops and commercializes proprietary ... its financial and operational results for the fiscal first ... press release are in Canadian dollars (CAD), unless otherwise ... continued to win new business from our existing customers ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Therapeutics (CTI),(Nasdaq and MTA: CTIC) announced today that it ... exchange for 6,634 shares of CTI,s Series A, B ... interest of all,series of CTI,s Convertible Preferred Stock. Each ... 7,143 shares of CTI,s common stock, at a,conversion price ...
... $65.0 MillionRICHMOND, Calif., Feb. 4 Sangamo BioSciences, Inc. (Nasdaq: ... year 2008 financial results and accomplishments and provided an outlook ... Sangamo reported a consolidated net loss of $2.6 million, or ... million, or $0.17 per share, for the same period in ...
... Specialty Pharmacy is,pleased to announce two new "Navigator" ... DSP launched both a Hemophilia and IVIG,Navigator Program. ... as National,Sales Manager for both programs. Reed is ... over 18 years of pharmaceutical sales experience. Most ...
Cached Biology Technology:Cell Therapeutics Exchanges 83% of Remaining Convertible Preferred Stock Into New Non-dividend Bearing, Non-redeemable Convertible Preferred Stock With Conversion Price of $0.14 per Share 2Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 2Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 3Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 4Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 5Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 6Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 7Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 8Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 9Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results 10Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program 2
Recombinant Mouse MMP-9, CF...
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Cyan Standard is 7-hydroxy-4-trifluoromethylcoumarin...
... Osmometer for 10 L sample. Ideal for small volume applications, including pediatric, neonatal, geriatric, general adult, ... in less than 3 minutes after turn-on. ... ... ...
Biology Products: